251 related articles for article (PubMed ID: 27270408)
1. [Molecular and immunohistochemical diagnostics in melanoma].
Schilling B; Griewank KG
Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
[TBL] [Abstract][Full Text] [Related]
2. [Molecular diagnostics in melanoma].
Lang R; Bauer JW; Laimer M
Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
[TBL] [Abstract][Full Text] [Related]
3. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
Wiesner T; Fried I; Cerroni L; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
[No Abstract] [Full Text] [Related]
5. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
6. Biomarkers in melanoma.
Griewank KG
Scand J Clin Lab Invest Suppl; 2016; 245():S104-12. PubMed ID: 27467728
[TBL] [Abstract][Full Text] [Related]
7. [Personalized therapy concepts for malignant melanoma].
Schlaak M; Kreuzberg N; Mauch C; Kurschat P
Internist (Berl); 2013 Feb; 54(2):188-93. PubMed ID: 23371260
[TBL] [Abstract][Full Text] [Related]
8. [Molecular testing in malignant melanoma].
Dundr P; Staněk L; Němejcová K; Jakša R
Cesk Patol; 2014 Jul; 50(3):127-31. PubMed ID: 25186593
[TBL] [Abstract][Full Text] [Related]
9. [Molecular classification and markers of malignant melanoma].
Tímár J; Hársing J; Somlai B
Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
[TBL] [Abstract][Full Text] [Related]
10. Differing biologic behaviors of desmoplastic melanoma subtypes: Insights based on histopathologic, immunohistochemical, and genetic analyses.
Yang K; Mahalingam M
J Am Acad Dermatol; 2020 Aug; 83(2):523-531. PubMed ID: 32068045
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnostics of melanomas].
Griewank KG
Pathologe; 2015 Feb; 36(1):30-6. PubMed ID: 25491471
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
13. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
14. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
March J; Hand M; Truong A; Grossman D
J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
17. Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.
Botti G; Marra L; Anniciello A; Scognamiglio G; Gigantino V; Cantile M
Int J Clin Exp Pathol; 2015; 8(9):9742-51. PubMed ID: 26617684
[TBL] [Abstract][Full Text] [Related]
18. [Immuno-diagnosis of malignant melanoma].
Szekeres G; Battyáni Z
Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic and predictive markers of malignant melanoma].
Rásó E; Barbai T; Gyõrffy B; Tímár J
Magy Onkol; 2013 Jun; 57(2):79-83. PubMed ID: 23795352
[TBL] [Abstract][Full Text] [Related]
20. New developments in biomarkers for melanoma.
Griewank KG; Ugurel S; Schadendorf D; Paschen A
Curr Opin Oncol; 2013 Mar; 25(2):145-51. PubMed ID: 23334230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
